Additionally, it is not yet clear what magnitude of exposure Stryker faces for damages related to the implants.Thanks to Boston Scientific 's historical underinvestment in its neurovascular segment, Stryker must now play catch up in order to maintain
Dec 11 (Reuters) - An advisory panel of medical experts voted on Wednesday to recommend that U.S. health regulators approve an experimental stroke-prevention device made by Boston Scientific Corp
* Says US FDA advisory committee votes 13-1 that benefits of Watchman anti-stroke device outweigh risks
solid core business and continued strong execution." In a colorful note, Mills calls the preliminary injunction against BSX 's Guidezilla extension catheter an "early Christmas present" and says "potential new reprocessing service could add
Dec 9 (Reuters) - U.S. Food and Drug Administration staff reviewing data on Boston Scientific Corp 's novel anti-stroke device highlighted the implant's failure to meet a key goal for effectiveness...
Dec 9 (Reuters) - Boston Scientific Corp 's anti-stroke device did not meet one measure of success in a clinical study of the implant, but other data must be considered when determining overall...
CHICAGO, Dec 9 (Reuters) - Boston Scientific Corp : * FDA emphasizes Boston Scientific anti-stroke device did not meet
By The Value Investor : Investors in Boston Scientific Corporation ( BSX ) have had a great year so far, as investors ..... Analysts at Benchmark initiated coverage on Boston Scientific with a "Hold" rating, accompanied by a price
patient injuries caused by its vaginal mesh products. The issue is not unique to Endo--competitors CR Bard, Boston Scientific , Johnson & Johnson, and others are facing litigation for similar products--but it could face a significant financial
Boston Scientific Corporation ( BSX ) 25th Annual Piper Jaffray Healthcare Conference Call December ..... team here at Piper Jaffray, very pleased to have the guys from Boston Scientific here Mike and Dan thanks for (inaudible) a little time out of